Efficacy and safety of Omalizumab (Xolair) for cholinergic urticaria in patients unresponsive to a double dose of antihistamines: A randomized mixed double-blind and open-label placebo-controlled clinical trial
- Publication date
- 1 January 2019
- Publisher
- 'Elsevier BV'